Want to track NAUT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nautilus Biotechnology, Inc. (NAUT) Statistics
Valuation metrics
Market Cap 222.39M
Enterprise value 235.36M
Trailing P/E (ttm) -3.78
Forward P/E -
PEG ratio -0.23
Price/Sales (ttm) -
Price/Book (mrq) 1.53
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 907.87K
Average volume (90 days) 480.16K
Price summary
52-Week low 0.62
52-Week high 4.31
Beta -
50-Day moving average 2
200-Day moving average 2.54
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.32%
Return on equity -0.35%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.76
Total debt (mrq) -
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 11.85%
Book value per share (mrq) 1.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
